University of Groningen at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

University of Groningen brings 1 presentation to ESGCT 2026 in Hamburg. Its program covers non-viral vectors and RNA therapeutics alongside how patients get access to gene and cell therapies.

OrganizationESGCT 2026 Attendance
University of Groningen
Groningen, Netherlands
Universities & institutes
Public research university in Groningen, Netherlands.
Chair
Wed Oct 28
8:30am–10:30am
SESSION 3d: Non-viral vectors/nanotechnology and RNA therapeutics I
with University of Lisbon
Vectors and delivery (AAV, lentiviral, LNP)RNA and oligonucleotide therapies
Talk
Thu Oct 29
8:50am–10:30am
SESSION 7c: Accessibility of GT
SESSION 7c: Accessibility of GT
Manufacturing, CMC and access
Chair
Fri Oct 30
11:00am–1:00pm
SESSION 12d: Non-viral vectors/Nanotechnology and RNA therapeutics II
with Fraunhofer Institute for Cell Therapy and Immunology (IZI)
Vectors and delivery (AAV, lentiviral, LNP)RNA and oligonucleotide therapies

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Groningen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction